Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder - Related Studies

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

This study is currently recruiting participants.

Study NCT00578097. Last updated on October 20, 2008. Information provided by Ipsen

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Overactive Bladder

2	Additional conditions recognized in this trial
		Urinary Bladder, Overactive

3	More general conditions related to this trial
		Signs and Symptoms
		Urinary Bladder Diseases
		Urologic Diseases
		Urological Manifestations

4	Interventions listed in this trial
		Botulinum type A (Dysport®)
		Placebo

5	Additional drug interventions recognized in this trial
		Botulinum Toxin Type A
		Botulinum Toxins

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Central Nervous System Agents
		Neuromuscular Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Ipsen